Ms. Chow, an associate in Orrick's Hong Kong office, is a member of the Corporate Group. Ms. Chow's practice focuses on corporate finance, mergers and acquisitions, private equity, general corporate and commercial law. She advises issuers and sponsors on the listing of securities on the Hong Kong Stock Exchange as well as listed companies on regulatory and compliance matters.
Ms. Chow has been involved in the following recent initial public offerings, representing:
Standard Chartered Securities (Hong Kong) Limited (formerly known as Cazenove Asia Limited) in the successful listing of China XLX Fertiliser Ltd. on the Main Board of the Hong Kong Stock Exchange by way of introduction. This transaction represents the first dual primary listing in Hong Kong of a Singapore-incorporated and Singapore-listed company.
361 Degrees International Limited in its HK$1.8 billion (US$233 million) initial public offering on the Main Board of the Hong Kong Stock Exchange. The sponsor was Merrill Lynch Far East Limited.
- Xtep International Holdings Limited in its HK$2.2 billion (US$286 million) initial public offering on the Main Board of the Hong Kong Stock Exchange. The joint sponsors were JP Morgan Securities (Asia Pacific) Limited and UBS AG.
The following is a sample of Ms. Chow's past representative matters:
- Acted for an electronics company and a pharmaceutical company on their initial public offerings.
- Advised on regulatory and compliance issues in addition to general commercial matters for sportswear companies, a ship trading and supplying company, a Chinese dairy company, an electronics company and a biotechnology company.
- Acted for various banks on loan transactions, project finance and general banking advice.
Print-friendly
web-friendly